NEWS
Austria has become the first European country to implement a total ban on glyphosate, the toxic weedkiller chemical suspected to cause cancer in people exposed to it.
COMMENT
German pharma-chemical company Bayer is now in deep trouble. Its disastrous $63 billion takeover of Monsanto in 2018 has led to it becoming subject to lawsuits from patients who say they developed cancer as a result of exposure to Roundup, Monsanto’s glyphosate-containing weedkiller. Previously, in an evaluation published in 2015, the World Health Organization’s International Agency for Research on Cancer had said that glyphosate is “probably carcinogenic to humans.”
Having already lost 3 glyphosate-related lawsuits that awarded multimillion-dollar payouts to the patients concerned, Bayer’s share price has plummeted. The company now faces a further 13,400 lawsuits from patients across the United States, as well as a first case filed against it in Australia.
With even Bayer’s credit-rating now under scrutiny, it isn’t just glyphosate and Roundup that are at threat, but also the future existence of the company itself.
Read article at france24.com
Researchers Say Millions Of People Who Take Daily Aspirin For Preventing Heart Attacks Should Stop
July 24, 2019Vitamin D Supplements May Help Stave Off Diabetes
July 26, 2019Austria Becomes First European Country To Ban Glyphosate Weedkiller
NEWS
Austria has become the first European country to implement a total ban on glyphosate, the toxic weedkiller chemical suspected to cause cancer in people exposed to it.
COMMENT
German pharma-chemical company Bayer is now in deep trouble. Its disastrous $63 billion takeover of Monsanto in 2018 has led to it becoming subject to lawsuits from patients who say they developed cancer as a result of exposure to Roundup, Monsanto’s glyphosate-containing weedkiller. Previously, in an evaluation published in 2015, the World Health Organization’s International Agency for Research on Cancer had said that glyphosate is “probably carcinogenic to humans.”
Having already lost 3 glyphosate-related lawsuits that awarded multimillion-dollar payouts to the patients concerned, Bayer’s share price has plummeted. The company now faces a further 13,400 lawsuits from patients across the United States, as well as a first case filed against it in Australia.
With even Bayer’s credit-rating now under scrutiny, it isn’t just glyphosate and Roundup that are at threat, but also the future existence of the company itself.
Read article at france24.comDr. Rath Health Foundation
Related posts
Germany Identifies its First Case of New Mpox Variant
Read more